Currently, there are 42.19M common shares owned by the public and among those 34.11M shares have been available to trade.
The company’s stock has a 5-day price change of 14.71% and 1.92% over the past three months. LFMD shares are trading 12.63% year to date (YTD), with the 12-month market performance down to -29.43% lower. It has a 12-month low price of $3.99 and touched a high of $12.88 over the same period. LFMD has an average intraday trading volume of 980.98K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.21%, -0.70%, and -4.14% respectively.
Institutional ownership of LifeMD Inc (NASDAQ: LFMD) shares accounts for 37.19% of the company’s 42.19M shares outstanding.
It has a market capitalization of $241.47M and a beta (3y monthly) value of 2.34. The earnings-per-share (ttm) stands at -$0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.64% over the week and 11.55% over the month.
Earnings per share for the fiscal year are expected to increase by 80.38%, and 250.64% over the next financial year.
Looking at the support for the LFMD, a number of firms have released research notes about the stock. Lake Street stated their Buy rating for the stock in a research note on December 10, 2024, with the firm’s price target at $12. Mizuho coverage for the LifeMD Inc (LFMD) stock in a research note released on December 04, 2024 offered a Neutral rating with a price target of $7. B. Riley Securities was of a view on August 23, 2024 that the stock is Buy, while KeyBanc Capital Markets gave the stock Overweight rating on June 05, 2024, issuing a price target of $12. Craig Hallum on their part issued Buy rating on November 30, 2023.
